Related Experiment Video
Updated: Mar 13, 2026

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
Delayed graft function and its management in children
1Department of Nephrology & Kidney Transplantation, The Children's Memorial Health Institute, Warsaw, Poland. r.grenda@czd.pl.
Insights
Delayed graft function (DGF) after kidney transplant is often caused by ischemia/reperfusion injury. Management focuses on minimizing risk factors and developing new pharmacologic strategies to prevent or treat this common post-transplant complication.
Area of Science:
- Nephrology
- Transplantation Immunology
- Surgical Research
Background:
- Delayed graft function (DGF) is a common complication following renal transplantation, defined by the need for dialysis within seven days post-transplant.
- Ischaemia/reperfusion (I/R) injury, encompassing microvascular inflammation, cell death, and apoptosis, is a primary mechanism underlying DGF.
- Several clinical factors, including donor characteristics (age, creatinine, cardiovascular stability), prolonged cold ischaemia time, and recipient BMI, are associated with an increased risk of DGF.
Purpose of the Study:
- To review the definition, underlying mechanisms, risk factors, and management strategies for DGF in renal transplantation.
- To discuss the impact of DGF on long-term graft function and the current approaches to its prevention and treatment.
- To highlight ongoing clinical trials evaluating novel pharmacologic strategies for I/R injury.
Main Methods:
- Literature review of studies defining DGF and its associated risk factors.
- Analysis of mechanisms including ischaemia/reperfusion injury and regenerative processes.
- Overview of current and emerging clinical and pharmacologic management strategies.
Main Results:
- DGF is linked to donor factors, recipient factors, and procurement/transplantation variables.
- Predictive formulas exist to assess DGF risk based on specific parameters.
- The long-term impact of DGF on graft function remains debated due to variations in organ donation types.
Conclusions:
- DGF is a multifactorial complication of renal transplantation, primarily driven by I/R injury.
- Management strategies involve mitigating individual risk factors and exploring targeted pharmacologic interventions.
- Further research and clinical trials are essential to optimize DGF prevention and treatment, potentially improving long-term transplant outcomes.
Abstract:
Delayed graft function (DGF) is commonly defined as the requirement for dialysis within the first 7 days following renal transplantation. The major underlying mechanism is related to ischaemia/reperfusion injury, which includes microvascular inflammation and cell death and apoptosis, and to the regeneration processes. Several clinical factors related to donor, recipient and organ procurement/transplantation procedures may increase the risk of DGF, including donor cardiovascular instability, older donor age, donor creatinine concentration, long cold ischaemia time and marked body mass index of both the donor and recipient. Some of these parameters have been used in specific predictive formulas created to assess the risk of DGF. A variety of other pre-, intra- and post-transplant clinical factors may also increase the risk of DGF, such as potential drug nephrotoxicity, surgical problems and/or hyperimmunization of the recipient. DGF may decrease the long-term graft function, but data on this effect are inconsistent, partially due to the many different types of organ donation. Relevant management strategies may be classified into the classic clinical approach, which has the aim of minimizing the individual risk factors of DGF, and specific pharmacologic strategies, which are designed to prevent or treat ischaemia/reperfusion injury. Both strategies are currently being evaluated in clinical trials.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Kidney Transplant I: Introduction
Kidney Transplant III: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

